U-Blot® Research Grade Onvapegleukin AlfaCat. No. WA3292Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Onvapegleukin AlfaCat. No. WA3292
U-Blot® Research Grade OntuxizumabCat. No. WA3291
U-Blot® Research Grade OntorpaceptCat. No. WA3290
U-Blot® Research Grade OntamalimabCat. No. WA3289
U-Blot® Research Grade OngericimabCat. No. WA3288
U-Blot® Research Grade Onfekafusp AlfaCat. No. WA3287
U-Blot® Research Grade OnerceptCat. No. WA3286
U-Blot® Research Grade OncolymCat. No. WA3285
U-Blot® Research Grade OnartuzumabCat. No. WA3284
U-Blot® Research Grade OnacrisantaspaseCat. No. WA3283
U-Blot® Research Grade ompekimigCat. No. WA3282
U-Blot® Research Grade OmoprubartCat. No. WA3281